| Net Cash Provided by (Used in) Operating Activities |
$348,049 |
USD |
|
Q3 2024 |
Q1 2024 |
| Net Cash Provided by (Used in) Financing Activities |
$64,949 |
USD |
132% |
Q3 2024 |
Q1 2024 |
| Net Cash Provided by (Used in) Investing Activities |
$675,826 |
USD |
|
Q3 2024 |
Q1 2024 |
| Common Stock, Shares Authorized |
75,000,000 |
shares |
0% |
Q2 2025 |
FY 2025 |
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q2 2025 |
FY 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$257,868 |
USD |
-3392% |
Q3 2024 |
Q1 2024 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$52,895 |
USD |
288% |
Q3 2024 |
Q1 2024 |
| Deferred Tax Assets, Gross |
$400,490 |
USD |
95% |
Q2 2025 |
FY 2025 |
| Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
$1,135,809 |
USD |
-0.04% |
Q2 2025 |
FY 2025 |
| Operating Lease, Liability, Current |
$5,441 |
USD |
56% |
Q2 2025 |
FY 2025 |
| Deferred Tax Assets, Operating Loss Carryforwards |
$62,628 |
USD |
107% |
Q2 2025 |
FY 2025 |
| Preferred Stock, Shares Issued |
0 |
shares |
|
Q2 2025 |
FY 2025 |
| Preferred Stock, Shares Authorized |
5,000,000 |
shares |
0% |
Q2 2025 |
FY 2025 |
| Additional Paid in Capital |
$4,765,455 |
USD |
112% |
Q2 2025 |
FY 2025 |
| Preferred Stock, Shares Outstanding |
0 |
shares |
|
Q2 2025 |
FY 2025 |
| Deferred Tax Assets, Net of Valuation Allowance |
$400,490 |
USD |
95% |
Q2 2025 |
FY 2025 |
| Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q2 2025 |
FY 2025 |